197 related articles for article (PubMed ID: 18280594)
1. TNFalpha antagonist upregulates interleukin-6 in rats with hypertensive heart failure.
Haugen E; Täng MS; Isic A; Andersson B; Fu M
Int J Cardiol; 2008 Oct; 130(1):64-8. PubMed ID: 18280594
[TBL] [Abstract][Full Text] [Related]
2. TNFalpha-antagonist neither improve cardiac remodelling or cardiac function at early stage of heart failure in diabetic rats.
Isic A; Scharin Tang M; Haugen E; Fu M
Autoimmunity; 2008 Sep; 41(6):473-7. PubMed ID: 18781474
[TBL] [Abstract][Full Text] [Related]
3. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
[TBL] [Abstract][Full Text] [Related]
4. The isolated working heart model in infarcted rat hearts.
Itter G; Jung W; Schoelkens BA; Linz W
Lab Anim; 2005 Apr; 39(2):178-93. PubMed ID: 15901361
[TBL] [Abstract][Full Text] [Related]
5. A model of chronic heart failure in spontaneous hypertensive rats (SHR).
Itter G; Jung W; Juretschke P; Schoelkens BA; Linz W
Lab Anim; 2004 Apr; 38(2):138-48. PubMed ID: 15070453
[TBL] [Abstract][Full Text] [Related]
6. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat.
Abbate A; Scarpa S; Santini D; Palleiro J; Vasaturo F; Miller J; Morales C; Vetrovec GW; Baldi A
Int J Cardiol; 2006 Aug; 111(3):371-6. PubMed ID: 16257070
[TBL] [Abstract][Full Text] [Related]
7. Chronic β-adrenoceptor antagonist treatment controls cardiovascular remodeling in heart failure in the aging spontaneously hypertensive rat.
Chan V; Fenning A; Hoey A; Brown L
J Cardiovasc Pharmacol; 2011 Oct; 58(4):424-31. PubMed ID: 21709583
[TBL] [Abstract][Full Text] [Related]
8. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat.
Loch D; Chan V; Hoey A; Brown L
Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):262-70. PubMed ID: 19583711
[TBL] [Abstract][Full Text] [Related]
10. Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model.
Zanella JM; Burright EN; Hildebrand K; Hobot C; Cox M; Christoferson L; McKay WF
Spine (Phila Pa 1976); 2008 Feb; 33(3):227-34. PubMed ID: 18303453
[TBL] [Abstract][Full Text] [Related]
11. Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats.
Meurrens K; Ruf S; Ross G; Schleef R; von Holt K; Schlüter KD
Cardiovasc Res; 2007 Nov; 76(2):311-22. PubMed ID: 17658497
[TBL] [Abstract][Full Text] [Related]
12. [Effect of beta3-adrenoceptor antagonist on the cardiac function and expression of endothelial nitric oxide synthase in a rat model of heart failure].
Gan RT; Li WM; Wang X; Wu S; Kong YH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):675-8. PubMed ID: 17996136
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
[TBL] [Abstract][Full Text] [Related]
14. Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure.
Schulze PC; Gielen S; Adams V; Linke A; Möbius-Winkler S; Erbs S; Kratzsch J; Hambrecht R; Schuler G
Basic Res Cardiol; 2003 Jul; 98(4):267-74. PubMed ID: 12835956
[TBL] [Abstract][Full Text] [Related]
15. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches.
Gullestad L; Aukrust P
Am J Cardiol; 2005 Jun; 95(11A):17C-23C; discussion 38C-40C. PubMed ID: 15925560
[TBL] [Abstract][Full Text] [Related]
16. Direct application of the TNF-alpha inhibitor, etanercept, does not affect CGRP expression and phenotypic change of DRG neurons following application of nucleus pulposus onto injured sciatic nerves in rats.
Norimoto M; Ohtori S; Yamashita M; Inoue G; Yamauchi K; Koshi T; Suzuki M; Orita S; Eguchi Y; Sugiura A; Ochiai N; Takaso M; Takahashi K
Spine (Phila Pa 1976); 2008 Oct; 33(22):2403-8. PubMed ID: 18824950
[TBL] [Abstract][Full Text] [Related]
17. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
18. Enhanced early after-myocardial infarction concentration of TNF-alpha subsequently increased circulating and myocardial adrenomedullin in spontaneously hypertensive rats.
Drímal J; Knezl V; Paulovicová E; Drímal D
Gen Physiol Biophys; 2008 Mar; 27(1):12-8. PubMed ID: 18436978
[TBL] [Abstract][Full Text] [Related]
19. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
Moutsopoulos NM; Katsifis GE; Angelov N; Leakan RA; Sankar V; Pillemer S; Wahl SM
Ann Rheum Dis; 2008 Oct; 67(10):1437-43. PubMed ID: 18198195
[TBL] [Abstract][Full Text] [Related]
20. Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage.
Jesmin S; Zaedi S; Maeda S; Togashi H; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):919-24. PubMed ID: 16741024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
